124
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Topical Erythropoietin for Treatment of Scleral Necrosis

, MD, MSc, , MD, , MD, , MD & , MD
Pages 1701-1706 | Received 20 Feb 2021, Accepted 20 May 2021, Published online: 14 Jun 2021

References

  • Alsagoff Z, Tan DT, Chee SP. Necrotising scleritis after bare sclera excision of pterygium. Br J Ophthalmol. 2000;84(9):1050–1052. doi:10.1136/bjo.84.9.1050.
  • Sridhar MS, Bansal AK, Rao GN. Surgically induced necrotizing scleritis after pterygium excision and conjunctival autograft. Cornea. 2002;21(3):305–307. doi:10.1097/00003226-200204000-00013.
  • Sharifipour F, Baradaran-Rafii A, Idani E, Zamani M, Jabbarpoor Bonyadi MH. Oxygen therapy for acute ocular chemical or thermal burns: a pilot study. Am J Ophthalmol. 2011;151(5):823–828. doi:10.1016/j.ajo.2010.11.005.
  • Vergouwen DPC, Rothova A, Ten Berge JC, et al. Current insights in the pathogenesis of scleritis. Exp Eye Res. 2020;197:108078. doi:10.1016/j.exer.2020.108078.
  • Doshi RR, Harocopos GJ, Schwab IR, Cunningham ET Jr. The spectrum of postoperative scleral necrosis. Surv Ophthalmol. 2013;58(6):620–633. doi:10.1016/j.survophthal.2012.11.002.
  • Sainz de la Maza M, Tauber J, Foster CS. Scleral grafting for necrotizing scleritis. Ophthalmology. 1989;96(3):306–310. doi:10.1016/S0161-6420(89)32892-2.
  • Kachmaryk M, Bouchard CS, Duffner LA. Bilateral fascia lata patch grafts in a patient with progressive scleromalacia perforans. Ophthalmic Surg Lasers. 1996;27(5):397–400. doi:10.3928/1542-8877-19960501-15.
  • Jain V, Shome D, Natarajan S, Narvekar R. Surgically induced necrotizing scleritis after pterygium surgery with conjunctival autograft. Cornea. 2008;27(6):720–721. doi:10.1097/01.ico.0000611420.34912.bc.
  • Sharma N, Kaur M, Agarwal T, Sangwan VS, Vajpayee RB. Treatment of acute ocular chemical burns. Surv Ophthalmol. 2018;63(2):214–235. doi:10.1016/j.survophthal.2017.09.005.
  • Yamazoe K, Shimazaki-Den S, Otaka I, Hotta K, Shimazaki J. Surgically induced necrotizing scleritis after primary pterygium surgery with conjunctival autograft. Clin Ophthalmol. 2011;5:1609–1611. doi:10.2147/OPTH.S24885.
  • Karalezli A, Kucukerdonmez C, Borazan M, Akova YA. Successful treatment of necrotizing scleritis after conjunctival autografting for pterygium with amniotic membrane transplantation. Orbit. 2010;29(2):88–90. doi:10.3109/01676830903297563.
  • Ti SE, Tan DTH. Tectonic corneal lamellar grafting for severe scleral melting after pterygium surgery. Ophthalmology. 2003;110(6):1126–1136. doi:10.1016/S0161-6420(03)00260-4.
  • Lee JS, Shin MK, Park JH, Park YM, Song M. Autologous advanced tenon grafting combined with conjunctival flap in scleromalacia after pterygium excision. J Ophthalmol. 2015;2015:547276. doi:10.1155/2015/547276.
  • Grasso G, Sfacteria A, Cerami A, Brines M. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist. 2004;10(2):93–98. doi:10.1177/1073858403259187.
  • Brines M, Cerami A. The receptor that tames the innate immune response. Mol Med. 2012;18(1):486–496. doi:10.2119/molmed.2011.00414.
  • Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res. 2002;64(2):326–333. doi:10.1006/mvre.2002.2426.
  • Pagonopoulou O, Efthimiadou A, Lambropoulou M, Papadopoulos N, Nikolettos NK. Erythropoietin and growth factors exhibit differential angiogenic potential in mouse heart. In Vivo. 2008;22:587–591.
  • Heeschen C, Aicher A, Lehmann R, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 2003;102(4):1340–1346. doi:10.1182/blood-2003-01-0223.
  • Feizi S, Kanavi MR, Safari S, Ebrahimi H, Javadi MA. Effects of topical erythropoietin on healing experimentally-induced avascular scleral damage in a rabbit model. Exp Eye Res. 2020;190:107898. doi:10.1016/j.exer.2019.107898.
  • Feizi S, Javadi MA. Topical erythropoietin as a novel treatment for necrotizing scleritis after pterygium surgery: a pilot study. Cornea. Nov 4, 2020. doi:10.1097/ICO.0000000000002570.
  • Roper-Hall MJ. Thermal and chemical burns. Trans Ophthalmol Soc UK. 1965;85:631–653.
  • Kase S, Osaki M, Jin XH, et al. Increased expression of erythropoietin receptor in human pterygial tissues. Int J Mol Med. 2007;20(5):699–702.
  • Takahashi Y, Takahashi S, Shiga Y, Yoshimi T, Miura T. Hypoxic induction of prolyl 4-hydroxylase alpha (I) in cultured cells. J Biol Chem. 2000;275(19):14139–14146. doi:10.1074/jbc.275.19.14139.
  • Livny E, Livnat T, Yakimov M, Masoud M, Weinberger D, Bahar I. Effect of erythropoietin on healing of corneal epithelial defects in rabbits. Ophthalmic Res. 2013;50(2):129–133. doi:10.1159/000351627.
  • Provatopoulou ST, Ziroyiannis PN. Clinical use of erythropoietin in chronic kidney disease: outcomes and future prospects. Hippokratia. 2011;15:109–115.
  • Annese T, Tamma R, Ruggieri S, Ribatti D. Erythropoietin in tumor angiogenesis. Exp Cell Res. 2019;374(2):266–273. doi:10.1016/j.yexcr.2018.12.013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.